Tower Research Capital LLC (TRC) - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 24 filers reported holding ELIEM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$21,472
+117.3%
3,020
-16.3%
0.00%
Q1 2024$9,880
+5.9%
3,606
+4.4%
0.00%
Q4 2023$9,328
-9.0%
3,455
-11.3%
0.00%
Q3 2023$10,246
-23.0%
3,896
-18.0%
0.00%
Q2 2023$13,311
+147800.0%
4,754
+45.7%
0.00%
Q1 2023$9
+350.0%
3,262
+408.1%
0.00%
Q4 2022$2
-99.9%
642
-34.6%
0.00%
Q3 2022$3,000
+200.0%
981
+123.0%
0.00%
Q2 2022$1,000
-95.0%
440
-81.9%
0.00%
Q1 2022$20,000
+100.0%
2,431
+142.9%
0.00%
Q4 2021$10,000
+11.1%
1,001
+103.9%
0.00%
Q3 2021$9,0004910.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RA Capital Management 13,150,849$236,452,0003.28%
Monashee Investment Management LLC 305,233$5,488,0001.01%
SAMLYN CAPITAL, LLC 1,681,025$30,225,0000.40%
Woodline Partners LP 387,224$6,962,0000.11%
TUDOR INVESTMENT CORP ET AL 287,294$5,166,0000.08%
CAAS CAPITAL MANAGEMENT LP 75,000$1,349,0000.03%
Hudson Bay Capital Management LP 100,000$1,798,0000.02%
GOLDMAN SACHS GROUP INC 165,952$2,984,0000.00%
HRT FINANCIAL LP 11,797$212,0000.00%
MILLENNIUM MANAGEMENT LLC 71,983$1,294,0000.00%
View complete list of ELIEM THERAPEUTICS INC shareholders